Skip to main content
K Phos Original — Prescription
PrescriptionORAL
🇺🇸United StatesPrescription

K Phos Original

Generic Formulation: POTASSIUM PHOSPHATE, MONOBASIC

Regulatory Registrant: Beach Products, Inc.

ORAL

Related NDC Products

NDC CodeDosage FormRouteCategory
82969-2096LIQUIDORALUNAPPROVED HOMEOPATHIC
42507-141TABLET, FILM COATEDORALANDA
57687-265SOLUTIONORALUNAPPROVED HOMEOPATHIC
68703-394LIQUIDORALUNAPPROVED HOMEOPATHIC
70677-1159SOLUTION/ DROPSOPHTHALMICOTC MONOGRAPH DRUG

Indications & Usage

INDICATONS AND USAGE For use in patients with elevated urinary pH. K-PHOS® ORIGINAL helps keep calcium soluble and reduces odor and rash caused by ammoniacal urine. Also, by acidifying the urine, it increases the antibacterial activity of methenamine mandelate and methenamine hippurate.

Dosage & Administration

DOSAGE AND ADMINISTRATION Two tablets dissolved in 6-8 oz. of water 4 times daily with meals and at bedtime. For best results, let the tablets soak in water for 2 to 5 minutes, or more if necessary, and stir. If any tablet particles remain undissolved, they may be crushed and stirred vigorously to speed dissolution.

Side Effects

ADVERSE REACTIONS Gastrointestinal upset (diarrhea, nausea, stomach pain, and vomiting) may occur with the use of potassium phosphate. Also, bone and joint pain (possible phosphate-induced osteomalacia) could occur. The following adverse effects may be observed with potassium administration: irregular heartbeat; dizziness; mental confusion; weakness or heaviness of legs; unusual tiredness; muscle cramps; numbness, tingling, pain, or weakness in hands or feet; numbness or tingling around lips; shortness of breath or troubled breathing.

Drug Interactions

Drug Interactions The use of antacids containing magnesium, calcium, or aluminum in conjunction with phosphate preparations may bind the phosphate and prevent its absorption. Potassium-containing medications or potassium-sparing diuretics may cause hyperkalemia when used concurrently with potassium salts. Patients should have serum potassium level determinations at periodic intervals. Concurrent use of salicylates may lead to increased serum salicylate levels since excretion of salicylates is reduced in acidified urine. Serum salicylate levels should be closely monitored to avoid toxicity.

Storage & Handling

STORAGE Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). Dispense in tight, light-resistant containers with child-resistant closures.

K Phos Original (FDA) — United States Medication Guide | U.S. Medication Information